Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting

scientific article published on 01 November 1996

Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-9149(96)00532-2
P698PubMed publication ID8916486

P2093author name stringA Mathur
S P Jain
G S Roubin
J S Yadav
L S Dean
M W Liu
J M Parks
C M Goods
K F al-Shaibi
S S Iyer
P2860cites workIntracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidanceQ28235915
The Canadian American Ticlopidine Study (CATS) in thromboembolic strokeQ34462070
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study GroupQ34540010
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator GroupQ42064869
Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplastyQ44290037
Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcomeQ70568674
A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantationQ70866645
Utilization of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasoundQ71089485
Sizing the Gianturco-Roubin coronary flexible coil stentQ72790728
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectaspirinQ18216
P304page(s)1042-1044
P577publication date1996-11-01
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleComparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting
P478volume78

Reverse relations

cites work (P2860)
Q77371764Abciximab administration and outcome after intracoronary stent implantation
Q33805244Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents
Q35368874Antiplatelet treatment with cilostazol after stent implantation.
Q48294670Aortic Source of Brain Embolism
Q28192340Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study
Q33329240Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.
Q74562161Clinical outcome at six months of coronary stenting followed by ticlopidine monotherapy
Q73250221Clopidogrel versus ticlopidine after intracoronary stent placement
Q33329991Comparison of cilostazol versus ticlopidine therapy after stent implantation
Q28194785Comparison of clopidogrel versus ticlopidine for prevention of minor myocardial injury after elective coronary stenting
Q73022264Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting
Q73014651Effects of cilostazol on angiographic restenosis after coronary stent placement
Q30305538Management of Acute Ischemic Coronary Syndromes: The Present and Future
Q28182051New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening
Q38008828Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor-a long continuing journey
Q33770499Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications.
Q28186141Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures
Q28186354The role of adenosine 5'-diphosphate receptor blockade in patients with cardiovascular disease
Q33588350Update in internal medicine
Q94558111Value of Antiplatelet Therapy in Preventing Thrombotic Events in Generalized Vascular Disease

Search more.